Uncategorized

Vaxcyte’s stock dips after biotech completes $1.42 billion stock offering

By September 6, 2024No Comments1 Min Read

Previous ArticleGoldman says Broadcom earnings were just a hiccup and to buy the dip

Next Article As Broadcom’s stock sells off, bulls say you can get this top AI play for cheap

Leave a ReplyCancel reply